Perspective: Edible vaccines - A concept coming of age

Tsafrir S. Mor; Miguel A. Gómez-Lim; Kenneth E. Palmer

doi:10.1016/S0966-842X(98)01357-2

Perspective: Edible vaccines - A concept coming of age

Tsafrir S. Mor, Miguel A. Gómez-Lim, Kenneth E. Palmer

Research output: Contribution to journal › Article › peer-review

68 Scopus citations

Abstract

In addition to their traditional role as a source of natural medicines, it is now possible to genetically engineer plants to produce pharmaceuticals. Transgenic plants expressing antigens from pathogenic microorganisms offer many advantages as low-cost production systems and effective delivery systems for vaccines. This new technology might contribute to global vaccine programs and might have a dramatic impact on health care in developing countries. Copyright (C) 1998 Elsevier Science Ltd.

Original language	English (US)
Pages (from-to)	449-453
Number of pages	5
Journal	Trends in microbiology
Volume	6
Issue number	11
DOIs	https://doi.org/10.1016/S0966-842X(98)01357-2
State	Published - Nov 1 1998
Externally published	Yes

ASJC Scopus subject areas

Microbiology
Microbiology (medical)
Infectious Diseases
Virology

Access to Document

10.1016/S0966-842X(98)01357-2

Cite this

@article{65f28bd1a0b2409aaec811d600a98f82,

title = "Perspective: Edible vaccines - A concept coming of age",

abstract = "In addition to their traditional role as a source of natural medicines, it is now possible to genetically engineer plants to produce pharmaceuticals. Transgenic plants expressing antigens from pathogenic microorganisms offer many advantages as low-cost production systems and effective delivery systems for vaccines. This new technology might contribute to global vaccine programs and might have a dramatic impact on health care in developing countries. Copyright (C) 1998 Elsevier Science Ltd.",

author = "Mor, {Tsafrir S.} and G{\'o}mez-Lim, {Miguel A.} and Palmer, {Kenneth E.}",

note = "Funding Information: T.S.M. is supported by a Postdoctoral Award (No. FI-251-97) from The United States–Israel Binational Agricultural Research and Development Fund (BARD). M.A.G-L. is a recipient of a CONACYT fellowship. K.E.P. acknowledges the support of the Foundation for Research Development (South Africa). The support of the Rockefeller Foundation is also gratefully acknowledged. ",

year = "1998",

month = nov,

day = "1",

doi = "10.1016/S0966-842X(98)01357-2",

language = "English (US)",

volume = "6",

pages = "449--453",

journal = "Trends in microbiology",

issn = "0966-842X",

publisher = "Elsevier Limited",

number = "11",

}

TY - JOUR

T1 - Perspective

T2 - Edible vaccines - A concept coming of age

AU - Mor, Tsafrir S.

AU - Gómez-Lim, Miguel A.

AU - Palmer, Kenneth E.

N1 - Funding Information: T.S.M. is supported by a Postdoctoral Award (No. FI-251-97) from The United States–Israel Binational Agricultural Research and Development Fund (BARD). M.A.G-L. is a recipient of a CONACYT fellowship. K.E.P. acknowledges the support of the Foundation for Research Development (South Africa). The support of the Rockefeller Foundation is also gratefully acknowledged.

PY - 1998/11/1

Y1 - 1998/11/1

N2 - In addition to their traditional role as a source of natural medicines, it is now possible to genetically engineer plants to produce pharmaceuticals. Transgenic plants expressing antigens from pathogenic microorganisms offer many advantages as low-cost production systems and effective delivery systems for vaccines. This new technology might contribute to global vaccine programs and might have a dramatic impact on health care in developing countries. Copyright (C) 1998 Elsevier Science Ltd.

AB - In addition to their traditional role as a source of natural medicines, it is now possible to genetically engineer plants to produce pharmaceuticals. Transgenic plants expressing antigens from pathogenic microorganisms offer many advantages as low-cost production systems and effective delivery systems for vaccines. This new technology might contribute to global vaccine programs and might have a dramatic impact on health care in developing countries. Copyright (C) 1998 Elsevier Science Ltd.

UR - http://www.scopus.com/inward/record.url?scp=0345367491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345367491&partnerID=8YFLogxK

U2 - 10.1016/S0966-842X(98)01357-2

DO - 10.1016/S0966-842X(98)01357-2

M3 - Article

C2 - 9846363

AN - SCOPUS:0345367491

SN - 0966-842X

VL - 6

SP - 449

EP - 453

JO - Trends in microbiology

JF - Trends in microbiology

IS - 11

ER -

Perspective: Edible vaccines - A concept coming of age

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this